Schedule 13D ownership disclosure

ACHILLES THERAPEUTICS PLC

Security class unavailable · CUSIP: 00449L102

Event date: 2022-12-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,607,834
Percent of class
3.9300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-131391
Form type
SC 13D/A
Filer
Achilles Therapeutics plc
CIK
CIK 1830749
Filed
Dec 30, 2022
Reporting period
Dec 28, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub